Moonyza Akmal Ahmad Kamil
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Moonyza Akmal Ahmad Kamil has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Abdul Manaf
1 shared publicationAdawiyah Jamil
Dermatology Unit Department of Medicine Universiti Kebangsaan Malaysia (UKM) Medical Centre Kuala Lumpur Malaysia
1 shared publicationAhmad Kamil
1 shared publicationAzahirafairud Abdul Rahim
Department of Internal Medicine, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia
1 shared publication- Azura Mohd Affandi
Department of Dermatology Hospital Kuala Lumpur Kuala Lumpur Malaysia
1 shared publication Cecilia E. Medianfar
Department of Dermatology, Zealand University Hospital, Roskilde, Denmark
1 shared publication
Latest Publications
- Open Access
- 7 July 2025
- Published by S. Karger AG in Dermatology
- Vol. 241 (Suppl. 1) , 69-75
Prevalence of Hidradenitis Suppurativa in Hospital Kuala Lumpur, Malaysia: A Cross-Sectional Study
Introduction: Hidradenitis suppurativa (HS) is a painful, chronic, recurring, debilitating, inflammatory skin disease affecting the areas rich in apocrine glands, with typical lesions (abscesses, nodules, discharging sinuses, and scars) and distribution (intertriginous areas). The prevalence of HS varies across geographical locality with lower rates reported in Asia. Methods: A cross-sectional, descriptive study, involving 500 consecutive healthy adults in Hospital Kuala Lumpur (HKL), was done from December 2022 to April 2023, to estimate the prevalence of HS in HKL, via a validated questionnaire. We included healthy hospital staff and those accompanying patients in the Department of Medicine. Consented participants would answer the screening questionnaire for HS, as well as the socio-demographic data questionnaire. The screened-positive participants were evaluated by a dermatologist to confirm the diagnosis of HS and to take clinical photos. Results: Ten participants were screened-positive for HS, but only 7 were confirmed cases. The prevalence of this study was 7/500 (1.4%). Majority had mild diseases (71% Hurley stage 1, 29% Hurley stage 2). HS was more prevalent among males (n = 4), lower education level (n = 4), and Chinese ethnicity (n = 3). There was no significant difference among the HS participants when compared to non-HS participants based on their age, gender, education level, income status, BMI, or smoking status (p > 0.05). Conclusion: HS is a complex disease with multifactorial elements to consider in its pathogenesis. The availability for early detection of mild HS disease, via a validated screening questionnaire, may change the paradigm of management of HS in the future.
- 7 July 2025
- Published by S. Karger AG in Dermatology
- Vol. 241 (Suppl. 1) , 69-75
Open AccessPrevalence of Hidradenitis Suppurativa in Hospital Kuala Lumpur, Malaysia: A Cross-Sectional Study
Introduction: Hidradenitis suppurativa (HS) is a painful, chronic, recurring, debilitating, inflammatory skin disease affecting the areas rich in apocrine glands, with typical lesions (abscesses, nodules, discharging sinuses, and scars) and distribution (intertriginous areas). The prevalence of HS varies across geographical locality with lower rates reported in Asia. Methods: A cross-sectional, descriptive study, involving 500 consecutive healthy adults in Hospital Kuala Lumpur (HKL), was done from December 2022 to April 2023, to estimate the prevalence of HS in HKL, via a validated questionnaire. We included healthy hospital staff and those accompanying patients in the Department of Medicine. Consented participants would answer the screening questionnaire for HS, as well as the socio-demographic data questionnaire. The screened-positive participants were evaluated by a dermatologist to confirm the diagnosis of HS and to take clinical photos. Results: Ten participants were screened-positive for HS, but only 7 were confirmed cases. The prevalence of this study was 7/500 (1.4%). Majority had mild diseases (71% Hurley stage 1, 29% Hurley stage 2). HS was more prevalent among males (n = 4), lower education level (n = 4), and Chinese ethnicity (n = 3). There was no significant difference among the HS participants when compared to non-HS participants based on their age, gender, education level, income status, BMI, or smoking status (p > 0.05). Conclusion: HS is a complex disease with multifactorial elements to consider in its pathogenesis. The availability for early detection of mild HS disease, via a validated screening questionnaire, may change the paradigm of management of HS in the future.
- Open Access
- 31 January 2023
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 6, e43910
Dermatologists’ Perceptions of the Use of Teledermatology in Managing Hidradenitis Suppurativa: Survey Study
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The COVID-19 pandemic has led to rapid adoption of teledermatology for the management of both acute and chronic skin disorders. Amongst conditions managed with teledermatology, Hidradenitis Suppurativa (HS) is a chronic inflammatory condition which due the nature of its skin lesions and the sites involved, is perceived to require recurrent clinical evaluation and may be subjected to privacy concerns amongst patients when managed over teledermatology. Objective: We sought to assess dermatologists’ perceptions of and experiences with teledermatology in managing HS. Methods: Participants were invited to completed a survey electronically, via a secure online platform. The survey was disseminated to members of the Asia Pacific Hidradenitis Suppurativa Foundation and through word of mouth, gathering responses over February to June 2022, from participants practicing in the Asia-Pacific region. Data pertaining to demographics and survey responses were collated. Associations between demographics and attitudes towards teledermatology for hidradenitis suppurativa was evaluated by multivariable ordered logistic regression. Attitudes towards teledermatology between hidradenitis suppurativa and atopic dermatitis were compared by random-effects ordered logistic regression, with adjustment for demographics. Results: 100 responses were obtained comprising of 76 (81.7%) dermatologists and 17 dermatology trainees (18.3%). There was equal representation of male and female gender. There was ambivalence amongst physicians regarding comfort and willingness to employ teledermatology for HS patients. Older physicians had increased tendency to express sentiments that it was difficult to accurately assess disease severity for HS, and concerns that patients may not be familiar with using teledermatology for HS. There was an overall increased tendency for physicians to perceive difficulty in managing HS compared to AD (assessed as a control cohort) – in terms of photography of hard-to-reach/sensitive areas (adjusted OR 4.71 (95% confidence interval: 2.44-9.07); p value < 0.001), accurate assessment (adjusted OR 2.66 (95% confidence interval: 1.48-4.79); p value 0.001), privacy issues from examination of private body areas (adjusted OR 2.75 (95% confidence interval 1.36-5.56); p value 0.005). Conclusions: This study, is the first, to our knowledge that assess physician attitudes towards the use of teledermatology in managing HS patients, and compares differential perspectives of its use on HS and AD patients. The findings of this study suggest that teledermatology is overall unsuitable for use in HS, but may be considered and useful in selected settings, for instance, for patients with quiescent or mild HS, patients with less HS involvement in intimate body areas, patients who were more willing to share documentation if required of affected body areas and in patients who already have an established and strong doctor-patient relationship with their HS provider. Physicians’ efforts should be focused on streamlining patient selection and optimizing consult environments for patients with HS. Clinical Trial: NA
- 31 January 2023
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 6, e43910
Open AccessDermatologists’ Perceptions of the Use of Teledermatology in Managing Hidradenitis Suppurativa: Survey Study
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The COVID-19 pandemic has led to rapid adoption of teledermatology for the management of both acute and chronic skin disorders. Amongst conditions managed with teledermatology, Hidradenitis Suppurativa (HS) is a chronic inflammatory condition which due the nature of its skin lesions and the sites involved, is perceived to require recurrent clinical evaluation and may be subjected to privacy concerns amongst patients when managed over teledermatology. Objective: We sought to assess dermatologists’ perceptions of and experiences with teledermatology in managing HS. Methods: Participants were invited to completed a survey electronically, via a secure online platform. The survey was disseminated to members of the Asia Pacific Hidradenitis Suppurativa Foundation and through word of mouth, gathering responses over February to June 2022, from participants practicing in the Asia-Pacific region. Data pertaining to demographics and survey responses were collated. Associations between demographics and attitudes towards teledermatology for hidradenitis suppurativa was evaluated by multivariable ordered logistic regression. Attitudes towards teledermatology between hidradenitis suppurativa and atopic dermatitis were compared by random-effects ordered logistic regression, with adjustment for demographics. Results: 100 responses were obtained comprising of 76 (81.7%) dermatologists and 17 dermatology trainees (18.3%). There was equal representation of male and female gender. There was ambivalence amongst physicians regarding comfort and willingness to employ teledermatology for HS patients. Older physicians had increased tendency to express sentiments that it was difficult to accurately assess disease severity for HS, and concerns that patients may not be familiar with using teledermatology for HS. There was an overall increased tendency for physicians to perceive difficulty in managing HS compared to AD (assessed as a control cohort) – in terms of photography of hard-to-reach/sensitive areas (adjusted OR 4.71 (95% confidence interval: 2.44-9.07); p value < 0.001), accurate assessment (adjusted OR 2.66 (95% confidence interval: 1.48-4.79); p value 0.001), privacy issues from examination of private body areas (adjusted OR 2.75 (95% confidence interval 1.36-5.56); p value 0.005). Conclusions: This study, is the first, to our knowledge that assess physician attitudes towards the use of teledermatology in managing HS patients, and compares differential perspectives of its use on HS and AD patients. The findings of this study suggest that teledermatology is overall unsuitable for use in HS, but may be considered and useful in selected settings, for instance, for patients with quiescent or mild HS, patients with less HS involvement in intimate body areas, patients who were more willing to share documentation if required of affected body areas and in patients who already have an established and strong doctor-patient relationship with their HS provider. Physicians’ efforts should be focused on streamlining patient selection and optimizing consult environments for patients with HS. Clinical Trial: NA
- Open Access
- 26 May 2020
- Published by Brieflands in Journal of Skin and Stem Cell
- Vol. 6 (4)
Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) Diagnosed by Controlled Attenuation Parameter on Transient Elastography and Its Predisposing Factors in Psoriasis
Psoriasis patients have an increased risk for non-alcoholic fatty liver disease (NAFLD). Controlled attenuation parameter (CAP) on transient elastography is ...
- 26 May 2020
- Published by Brieflands in Journal of Skin and Stem Cell
- Vol. 6 (4)
Open AccessPrevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) Diagnosed by Controlled Attenuation Parameter on Transient Elastography and Its Predisposing Factors in Psoriasis
Psoriasis patients have an increased risk for non-alcoholic fatty liver disease (NAFLD). Controlled attenuation parameter (CAP) on transient elastography is ...
- Open Access
- 22 May 2018
- Published by Wiley in Dermatology Research and Practice
- Vol. 2018, 1-9
Hidradenitis Suppurativa in Kuala Lumpur, Malaysia: A 7-Year Retrospective Review
Introduction. Hidradenitis Suppurativa (HS) is a chronic inflammatory skin condition characterized by inflamed nodules, abscesses, sinus tracts, and scarring, which can occur in any skin containing folliculopilosebaceous units. We aim to identify the demographic and clinical characteristics and treatment modalities in patients with HS. Methods. A retrospective analysis involving records of patients diagnosed with HS in Hospital Kuala Lumpur from July 2009 to June 2016. Results. Sixty-two patients were identified, with equal cases involving males and females. Majority of patients were Malays (41.9%), followed by Indians (35.5%), Chinese (17.7%), and other ethnicities (4.8%). Median age at diagnosis was 25 (IQR: 14) years. There is a delay in diagnosis with a median of 24 (IQR: 52) months. Most of the patients had lesions on the axilla (85.5%), followed by groin (33.9%) and gluteal region (29%). Gluteal lesions were more common in males. Nodules (67.7%), sinuses (56.5%), and abscesses (33.9%) were the main clinical features, with 43.5% classified under Hurley stage 2. There was no difference in terms of symptoms and types of lesions among different ethnicities and genders. Majority received systemic antibiotics, more than half had retinoid, and third of the patients had surgical intervention. Conclusions. A prompt recognition of HS is imperative, to screen for comorbidities and to initiate early treatment to reduce physical and psychological complications.
- 22 May 2018
- Published by Wiley in Dermatology Research and Practice
- Vol. 2018, 1-9
Open AccessHidradenitis Suppurativa in Kuala Lumpur, Malaysia: A 7-Year Retrospective Review
Introduction. Hidradenitis Suppurativa (HS) is a chronic inflammatory skin condition characterized by inflamed nodules, abscesses, sinus tracts, and scarring, which can occur in any skin containing folliculopilosebaceous units. We aim to identify the demographic and clinical characteristics and treatment modalities in patients with HS. Methods. A retrospective analysis involving records of patients diagnosed with HS in Hospital Kuala Lumpur from July 2009 to June 2016. Results. Sixty-two patients were identified, with equal cases involving males and females. Majority of patients were Malays (41.9%), followed by Indians (35.5%), Chinese (17.7%), and other ethnicities (4.8%). Median age at diagnosis was 25 (IQR: 14) years. There is a delay in diagnosis with a median of 24 (IQR: 52) months. Most of the patients had lesions on the axilla (85.5%), followed by groin (33.9%) and gluteal region (29%). Gluteal lesions were more common in males. Nodules (67.7%), sinuses (56.5%), and abscesses (33.9%) were the main clinical features, with 43.5% classified under Hurley stage 2. There was no difference in terms of symptoms and types of lesions among different ethnicities and genders. Majority received systemic antibiotics, more than half had retinoid, and third of the patients had surgical intervention. Conclusions. A prompt recognition of HS is imperative, to screen for comorbidities and to initiate early treatment to reduce physical and psychological complications.